RY 165.17 0.7872% SHOP 136.69 0.3745% TD 87.34 0.7614% ENB 64.64 0.2948% BN 73.7 -0.0271% TRI 254.59 1.0117% CNQ 40.77 -0.3178% CP 98.97 -0.2821% CNR 132.41 -0.6602% BMO 131.33 -0.8606% BNS 68.53 0.735% CSU 4925.0 -0.055% CM 86.35 0.9351% MFC 42.31 0.4034% ATD 72.49 -0.5624% NGT 73.65 -1.4848% TRP 69.36 -0.0576% SU 49.45 0.2026% WCN 268.41 0.041% L 217.45 -0.1424%
_04_29_2025_15_43_14_412732.jpg)
Recursion Pharmaceuticals, Inc
Recursion Pharmaceuticals, Inc (NASDAQ: RXRX) is a clinical-stage TechBio company focused on transforming drug discovery through the integration of biology and technology. Its proprietary Recursion Operating System (OS) leverages a broad array of technologies to explore and interpret trillions of biological and chemical interactions within the expansive Recursion Data Universe. By combining physical experiments with digital modeling in iterative feedback loops—blending laboratory work ("atoms") with computational analysis ("bits")—the company efficiently scales data generation in biology and chemistry. This integrated approach enables rapid validation of computer-generated hypotheses and accelerates the discovery of novel therapeutic compounds.
Technical Observation (on the daily chart):
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
CA
NZ
UK
US
AU
IND
Please wait processing your request...